COVID-19 in B Cell-Depleted Patients After Rituximab: A Diagnostic and Therapeutic Challenge.

COVID-19 in B Cell-Depleted Patients After Rituximab: A Diagnostic and Therapeutic Challenge.
复制标题

DOI:
10.3389/fimmu.2021.763412
复制
发表时间:
2021
影响因子:
7.3
通讯作者:
Scotton P
Scotton P
中科院分区:
医学2区
文献类型:
--
作者:
Furlan A;Forner G;Cipriani L;Vian E;Rigoli R;Gherlinzoni F;Scotton P

文献摘要

参考文献

被引文献

相似文献

B cell-targeting strategies such as rituximab are widely used in B cell hematologic malignancies, rheumatologic and musculoskeletal diseases and a variety of autoimmune disorders. The purpose of this paper is to illustrate how exposure to anti-CD20 treatment profoundly affects B cell functions involved in anti-SARS-CoV-2 immunity and significantly impacts on the clinical and serological course of SARS-CoV-2 infection, long term immunity and vaccine responses. The data presented here suggest that the effects of B cell-depleting agents on adaptive immunity should be taken into account for the proper selection and interpretation of SARS-CoV-2 diagnostics and to guide appropriate therapeutic approaches and protective measures. Combination therapeutic strategies including immunotherapy in association with prolonged antiviral treatment may play a decisive role in the setting of B cell immune deficiencies.
DOI: 10.1177/17562864211012835
发表时间: 2021
影响因子: 5.9
作者:
Achiron A;Mandel M;Dreyer-Alster S;Harari G;Magalashvili D;Sonis P;Dolev M;Menascu S;Flechter S;Falb R;Gurevich M
通讯作者: Gurevich M
DOI: 10.1038/s41573-020-00092-2
发表时间: 2021-03
期刊: Nature reviews. Drug discovery
影响因子: --
作者:
Lee DSW;Rojas OL;Gommerman JL
通讯作者: Gommerman JL
DOI: 10.3389/fonc.2020.01578
发表时间: 2020-09-02
影响因子: 4.7
作者:
Kos, Igor;Balensiefer, Benedikt;Kaddu-Mulindwa, Dominic
通讯作者: Kaddu-Mulindwa, Dominic
DOI: 10.1056/nejmoa2103784
发表时间: 2021-11-18
期刊: The New England journal of medicine
影响因子: --
作者:
Korley FK;Durkalski-Mauldin V;Yeatts SD;Schulman K;Davenport RD;Dumont LJ;El Kassar N;Foster LD;Hah JM;Jaiswal S;Kaplan A;Lowell E;McDyer JF;Quinn J;Triulzi DJ;Van Huysen C;Stevenson VLW;Yadav K;Jones CW;Kea B;Burnett A;Reynolds JC;Greineder CF;Haas NL;Beiser DG;Silbergleit R;Barsan W;Callaway CW;SIREN-C3PO Investigators
通讯作者: SIREN-C3PO Investigators
DOI: 10.1182/blood.2021011568
发表时间: 2021-06-10
期刊: Blood
影响因子: 20.3
作者:
Herishanu Y;Avivi I;Aharon A;Shefer G;Levi S;Bronstein Y;Morales M;Ziv T;Shorer Arbel Y;Scarfò L;Joffe E;Perry C;Ghia P
通讯作者: Ghia P